Placenta
Volume 29 , Pages 121-125 , October 2008

Parthenogenetic Activation: Biology and Applications in the ART Laboratory

  • A. Paffoni

      Affiliations

    • Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Infertility Unit, via M. Fanti 6, 20122 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 55034305; fax: +39 02 55034302.
  • ,
  • T.A.L. Brevini

      Affiliations

    • Laboratory of Biomedical Embryology, Center for Stem Cell Research, University of Milan, via Celoria 10, 20133 Milan, Italy
  • ,
  • F. Gandolfi

      Affiliations

    • Laboratory of Biomedical Embryology, Center for Stem Cell Research, University of Milan, via Celoria 10, 20133 Milan, Italy
  • ,
  • G. Ragni

      Affiliations

    • Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Infertility Unit, via M. Fanti 6, 20122 Milan, Italy

,Accepted 7 August 2008.

References 

  1. Hipp J, Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod. 2004;1:3
  2. Barton SC, Adams CA, Norris ML, Surani MA. Development of gynogenetic and parthenogenetic inner cell mass and trophectoderm tissues in reconstituted blastocysts in the mouse. J Embryol Exp Morphol. 1985;90:267–285
  3. Loi P, Ledda S, Fulka J, Cappai P, Moor RM. Development of parthenogenetic and cloned ovine embryos: effect of activation protocols. Biol Reprod. 1998;58:1177–1187
  4. Fukui Y, Sawai K, Furudate M, Sato N, Iwazumi Y, Ohsaki K. Parthenogenetic development of bovine oocytes treated with ethanol and cytochalasin B after in vitro maturation. Mol Reprod Dev. 1992;33:357–362
  5. Kure-bayashi S, Miyake M, Okada K, Kato S. Successful implantation of in vitro-matured, electro-activated oocytes in the pig. Theriogenology. 2000;53:1105–1119
  6. Ozil JP. The parthenogenetic development of rabbit oocytes after repetitive pulsatile electrical stimulation. Development. 1990;109:117–127
  7. Marshall VS, Wilton LJ, Moore HD. Parthenogenetic activation of marmoset (Callithrix jacchus) oocytes and the development of marmoset parthenogenones in vitro and in vivo. Biol Reprod. 1998;59:1491–1497
  8. Kaufman MH, Barton SC, Surani MA. Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature. 1977;265:53–55
  9. Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature. 1984;308:548–550
  10. Sturm KS, Flannery ML, Pedersen RA. Abnormal development of embryonic and extraembryonic cell lineages in parthenogenetic mouse embryos. Dev Dyn. 1994;201:11–28
  11. Barton SC, Surani MA, Norris ML. Role of paternal and maternal genomes in mouse development. Nature. 1984;311:374–376
  12. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature. 2001;414:122–128
  13. Hall JG. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet. 1990;46:857–873
  14. John RM, Surani MA. Imprinted genes and regulation of gene expression by epigenetic inheritance. Curr Opin Cell Biol. 1996;8:348–353
  15. Kono T, Obata Y, Wu Q, Niwa K, Ono Y, Yamamoto Y, et al. Birth of parthenogenetic mice that can develop to adulthood. Nature. 2004;428:860–864
  16. Feil R, Walter J, Allen ND, Reik W. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development. 1994;120:2933–2943
  17. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000;405:486–489
  18. Arney KL. H19 and Igf2 – enhancing the confusion?. Trends Genet. 2003;19:17–23
  19. Escriba MJ, Garcia-Ximenez F. Influence of sequence duration and number of electrical pulses upon rabbit oocyte activation and parthenogenetic in vitro development. Anim Reprod Sci. 2000;59:99–107
  20. Kim NH, Uhm SJ, Ju JY, Lee HT, Chung KS. Blastocoele formation and cell allocation to the inner cell mass and trophectoderm in haploid and diploid pig parthenotes developing in vitro. Zygote. 1997;5:365–370
  21. Lagutina I, Lazzari G, Duchi R, Galli C. Developmental potential of bovine androgenetic and parthenogenetic embryos: a comparative study. Biol Reprod. 2004;70:400–405
  22. Mognetti B, Sakkas D. Defects in the allocation of cells to the inner cell mass and trophectoderm of parthenogenetic mouse blastocysts. Reprod Fertil Dev. 1996;8:1193–1197
  23. Henery CC, Kaufman MH. Cleavage rate of haploid and diploid parthenogenetic mouse embryos during the preimplantation period. Mol Reprod Dev. 1992;31:258–263
  24. Balakier H, Tarkowski AK. Diploid parthenogenetic mouse embryos produced by heat-shock and cytochalasin B. J Embryol Exp Morphol. 1976;35:25–39
  25. Kubiak J, Paldi A, Weber M, Maro B. Genetically identical parthenogenetic mouse embryos produced by inhibition of the first meiotic cleavage with cytochalasin D. Development. 1991;111:763–769
  26. Rougier N, Werb Z. Minireview: parthenogenesis in mammals. Mol Reprod Dev. 2001;59:468–474
  27. Rinaudo P, Pepperell JR, Buradgunta S, Massobrio M, Keefe DL. Dissociation between intracellular calcium elevation and development of human oocytes treated with calcium ionophore. Fertil Steril. 1997;68:1086–1092
  28. Mitalipov SM, Nusser KD, Wolf DP. Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol Reprod. 2001;65:253–259
  29. Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med. 1975;292:63–66
  30. Strain L, Warner JP, Johnston T, Bonthron DT. A human parthenogenetic chimaera. Nat Genet. 1995;11:164–169
  31. Plachot M, Mandelbaum J, de Grouchy J. In vitro parthenogenesis in the human species, Ann Genet. 1984;27:158–161
  32. Winston N, Johnson M, Pickering S, Braude P. Parthenogenetic activation and development of fresh and aged human oocytes. Fertil Steril. 1991;56:904–912
  33. Rhoton-Vlasak A, Lu PY, Barud KM, Dewald GW, Hammitt DG. Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research. J Assist Reprod Genet. 1996;13:793–796
  34. Lin H, Lei J, Wininger D, Nguyen MT, Khanna R, Hartmann C, et al. Multilineage potential of homozygous stem cells derived from metaphase II oocytes. Stem Cells. 2003;21:152–161
  35. Nakagawa K, Yamano S, Nakasaka H, Hinokio K, Yoshizawa M, Aono T. A combination of calcium ionophore and puromycin effectively produces human parthenogenones with one haploid pronucleus. Zygote. 2001;9:83–88
  36. Paffoni A, Brevini TA, Somigliana E, Restelli L, Gandolfi F, Ragni G. In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection. Fertil Steril. 2007;87:77–82
  37. Liu L, Yang X. Interplay of maturation-promoting factor and mitogen-activated protein kinase inactivation during metaphase-to-interphase transition of activated bovine oocytes. Biol Reprod. 1999;61:1–7
  38. Grupen CG, Mau JC, McIlfatrick SM, Maddocks S, Nottle MB. Effect of 6-dimethylaminopurine on electrically activated in vitro matured porcine oocytes. Mol Reprod Dev. 2002;62:387–396
  39. Brevini TA, Gandolfi F. Parthenotes as a source of embryonic stem cells. Cell Prolif. 2008;41(Suppl. 1):20–30
  40. Jones HW, Cohen J. Experimentation on the preembryo. International Federation of Fertility Societies (IFFS) Surveillance 2007. Fertil Steril. 2007;87:S52–S68[chapter 16]
  41. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. 52nd General Assembly, Edinburgh, Scotland, 2000.
  42. CIOMS/WHO . International ethical guidelines for biomedical research involving human subjects. Geneve: CIOMS; 1993;
  43. Grupen CG, Verma PJ, Du ZT, McIlfatrick SM, Ashman RJ, Nottle MB. Activation of in vivo- and in vitro-derived porcine oocytes by using multiple electrical pulses. Reprod Fertil Dev. 1999;11:457–462
  44. Latham KE, Kutyna K, Wang Q. Genetic variation in trophectoderm function in parthenogenetic mouse embryos. Dev Genet. 1999;24:329–335
  45. Rogers NT, Hobson E, Pickering S, Lai FA, Braude P, Swann K. Phospholipase Czeta causes Ca2+ oscillations and parthenogenetic activation of human oocytes. Reproduction. 2004;128:697–702
  46. Hardy K, Handyside AH. Metabolism and cell allocation during parthenogenetic preimplantation mouse development. Mol Reprod Dev. 1996;43:313–322
  47. Plante L, King WA. In vitro development of spontaneously activated bovine oocytes. J Assist Reprod Genet. 1996;13:435–446
  48. de Fried EP, Ross P, Zang G, Divita A, Cunniff K, Denaday F, et al. Human parthenogenetic blastocysts derived from noninseminated cryopreserved human oocytes. Fertil Steril. 2008;89:943–947
  49. Ragni G, Paffoni A, Alagna F, Restelli L, Somigliana E. Reduced developmental potential of human oocytes after vitrification compared to slow freezing. Fertil Steril. 2007;88:S345
  50. Green RM. Can we develop ethically universal embryonic stem-cell lines?. Nat Rev Genet. 2007;8:480–485
  51. Brevini T, Cillo F, Tosetti V, Crestan M, Paffoni A, Ragni G, et al. Human pluripotent stem cells derived by parthenogenesis. Abstract of Keystone Symposia on Stem Cells, Whistler, BC, 2006: 54.
  52. Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2007;9:432–449
  53. Landry DW, Zucker HA. Embryonic death and the creation of human embryonic stem cells. J Clin Invest. 2004;114:1184–1186
  54. Munne S, Velilla E, Colls P, Garcia Bermudez M, Vemuri MC, Steuerwald N, et al. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertil Steril. 2005;84:1328–1334
  55. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature. 2006;444:481–485
  56. Alberio R, Campbell KH, Johnson AD. Reprogramming somatic cells into stem cells. Reproduction. 2006;132:709–720
  57. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007;1:55–70
  58. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  59. Lin G, OuYang Q, Zhou X, Gu Y, Yuan D, Li W, et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 2007;17:999–1007
  60. Mai Q, Yu Y, Li T, Wang L, Chen MJ, Huang SZ, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res. 2007;17:1008–1019
  61. de la Chapelle A. Microsatellite instability. N Engl J Med. 2003;349:209–210
  62. Dighe V, Clepper L, Pedersen D, Byrne J, Ferguson B, Gokhale S, et al. Heterozygous embryonic stem cell lines derived from nonhuman primate parthenotes. Stem Cells. 2008;26:756–766
  63. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148–1159

PII: S0143-4004(08)00242-7

doi: 10.1016/j.placenta.2008.08.005

Placenta
Volume 29 , Pages 121-125 , October 2008